about
Bispecific antibodies for cancer therapy: the light at the end of the tunnel?In vivo detection of small tumour lesions by multi-pinhole SPECT applying a (99m)Tc-labelled nanobody targeting the Epidermal Growth Factor Receptor.Single-domain antibody-SH3 fusions for efficient neutralization of HIV-1 Nef functionsSpecific photoaffinity-labeling of Tyr-50 on the heavy chain and of Tyr-32 on the light chain in the steroid combining site of a mouse monoclonal anti-estradiol antibody using C3-, C6-, and C7-linked 5-azido-2-nitrobenzoylamidoestradiol photoreagentCyclic peptides selected by phage display mimic the natural epitope recognized by a monoclonal anti-colicin A antibody.Isolation and characterization of antagonist and agonist peptides to the human melanocortin 1 receptor.Generation of llama single-domain antibodies against methotrexate, a prototypical hapten.Isolation and characterization of anti-FcgammaRIII (CD16) llama single-domain antibodies that activate natural killer cells.Growth and skeletal development in families with NOGGIN gene mutations.A llama single domain anti-idiotypic antibody mimicking HER2 as a vaccine: Immunogenicity and efficacy.Translocation of a functional protein by a voltage-dependent ion channel.A FcγRIII-engaging bispecific antibody expands the range of HER2-expressing breast tumors eligible to antibody therapy.Drift of the HIV-1 envelope glycoprotein gp120 toward increased neutralization resistance over the course of the epidemic: a comprehensive study using the most potent and broadly neutralizing monoclonal antibodies.Site-directed mutagenesis of the COOH-terminal region of colicin A: effect on secretion and voltage-dependent channel activityStrong and oriented immobilization of single domain antibodies from crude bacterial lysates for high-throughput compatible cost-effective antibody array generationSelection of intracellular single-domain antibodies targeting the HIV-1 Vpr protein by cytoplasmic yeast two-hybrid system.Anti-Mesothelin Nanobodies for Both Conventional and Nanoparticle-Based Biomedical Applications.The channel domain of colicin A is inhibited by its immunity protein through direct interaction in the Escherichia coli inner membrane.Lipoprotein nature of the colicin A lysis protein: effect of amino acid substitutions at the site of modification and processing.Straightforward selection of broadly neutralizing single-domain antibodies targeting the conserved CD4 and coreceptor binding sites of HIV-1 gp120The timing of carotid endarterectomy post stroke.V1/V2 Neutralizing Epitope is Conserved in Divergent Non-M Groups of HIV-1Polymerase chain reaction-based site-directed mutagenesis using magnetic beads.State of the art in tumor antigen and biomarker discovery.Therapeutic antibodies: successes, limitations and hopes for the future.Semiconductor quantum dots for multiplexed bio-detection on solid-state microarrays.Masked selection: a straightforward and flexible approach for the selection of binders against specific epitopes and differentially expressed proteins by phage display.Analysis of a conformational B cell epitope of human thyroid peroxidase: identification of a tyrosine residue at a strategic location for immunodominance.Detection of carcinoembryonic antigen using single-domain or full-size antibodies stained with quantum dot conjugates.Conformational nanobodies reveal tethered epidermal growth factor receptor involved in EGFR/ErbB2 predimers.Highly sensitive single domain antibody-quantum dot conjugates for detection of HER2 biomarker in lung and breast cancer cells.Oriented conjugates of single-domain antibodies and quantum dots: toward a new generation of ultrasmall diagnostic nanoprobes.Llama single-domain antibodies directed against nonconventional epitopes of tumor-associated carcinoembryonic antigen absent from nonspecific cross-reacting antigen.Synthetic elastomeric chains: a literature review.Effect of the 21-bp repeat upstream element on in vitro transcription from the early and late SV40 promoters.Determinants of the proton selectivity of the colicin A channel.Avascular necrosis of the hip and diffuse idiopathic skeletal hyperostosis during long-term isotretinoin treatment of epidermolytic ichthyosis due to a novel deletion mutation in KRT10.Fluorescence energy transfer distance measurements using site-directed single cysteine mutants. The membrane insertion of colicin A.Inhibition of the Nef regulatory protein of HIV-1 by a single-domain antibody.Functional characterization of an anti-estradiol antibody by site-directed mutagenesis and molecular modelling: modulation of binding properties and prominent role of the V(L) domain in estradiol recognition.
P50
Q24644083-1ADD1146-8850-40E1-94F5-3026EA171214Q27342927-02535381-5E5E-4CA6-808D-BE3D83390434Q30010165-328AA4AC-A8A3-4895-ACC9-39BFD53929EBQ30773384-14336324-0162-4CFA-AA48-A3C957A845BFQ31132706-65C1835B-290B-4915-B9A9-F3345D8524CCQ33215069-1413B1A9-E177-4679-B7BE-3E952775798EQ33258925-2F36A0E8-5928-4C73-840D-7919E37810FFQ33309759-59AA2911-C6ED-4923-9C53-41023B5074EBQ33315323-3367EEDA-4065-40F0-B63D-87FE0B89CCA3Q33467203-2B6DB47E-E985-4CD2-93EC-A6C367BA97C2Q34008983-9FAE3930-8CC9-4574-81BD-065FA9D91713Q34221898-C7B8BE2D-9C38-4EC7-A968-C4F2C7ECF95CQ34594036-F47CD42A-4603-4888-A4EB-564BF7CE57C3Q34598964-650CCBB8-90D8-4A42-8C73-2006E38BED6AQ34716655-1BBE1FBD-6A63-4A52-B444-14F6D81FE88DQ35462984-24349159-1981-4FCC-8600-9FE3DCF8255CQ35755580-F4223E63-4F78-426B-ABB8-AE90C7962EB6Q35849933-CB2080BE-B2A8-4E23-A082-E1BF6F38A3F3Q36238201-D01899CB-163B-4ADC-AD3A-2F88F71A9B34Q36559665-27BD5BCD-1EA9-489D-867C-B72A470212B5Q36578472-909E23C6-9D80-4F2F-906E-AF97FF3DD1F9Q36628369-BD82F9B7-EA77-4CF7-8CF1-FA68005A64CEQ36808642-2ACF4F3B-0774-4172-A453-7F04F05BD21DQ37132800-33DA479D-E28E-46A2-9964-0290FE48C3BEQ37491236-54D44A09-E409-4275-A0D4-2A002B31839DQ37495168-EBF55B0B-6369-4CAA-A6B2-D349BFDD50E9Q37563941-6AAB65A5-A2CC-4ACF-8DF3-3AB8802214C9Q38290508-42BD4F7A-4657-4319-A97C-A6A61D247458Q38900526-A68E6E4C-E716-4CEF-84AA-7EBAD83292E0Q38918393-D6013AF9-E517-4B7D-A0FC-9BDA7FFB9F12Q38990561-38DD7EB5-6274-456A-BC57-E9C21A5F5BF9Q39490969-B43D4E8D-C086-43B7-8C94-9E060409E4C9Q39837303-035A7B54-B82B-49C5-BDED-7D0B1CDAAF83Q40759470-76B7A7FB-4D7C-4A63-AAE4-928EC3A50533Q41582020-6BB1AD35-3521-4F11-9C7C-57009382B5B6Q43066648-B9CF90A4-CEB4-4A19-AEB8-EBC942911422Q43090949-5A17C852-E133-4828-9AAA-8532F5E14988Q43558159-9C4B00DB-6AA8-43E2-B33A-34E256BEC3D7Q43808114-4917904D-D024-4195-8E5B-A1A43002B331Q43900384-3FAC464A-011C-4B8A-9B94-69F44AFAB872
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Daniel Baty
@ast
Daniel Baty
@en
Daniel Baty
@es
Daniel Baty
@fr
Daniel Baty
@nl
Daniel Baty
@sl
type
label
Daniel Baty
@ast
Daniel Baty
@en
Daniel Baty
@es
Daniel Baty
@fr
Daniel Baty
@nl
Daniel Baty
@sl
prefLabel
Daniel Baty
@ast
Daniel Baty
@en
Daniel Baty
@es
Daniel Baty
@fr
Daniel Baty
@nl
Daniel Baty
@sl
P214
P106
P21
P213
0000 0000 0176 5874
P214
P31
P496
0000-0001-8443-4444
P734
P735
P7859
viaf-27133672